When the National Institutes of Health (NIH) announced in July that it would move forward with a Biden-era proposal to require “access plans” for companies seeking to license NIH-owned patents, the decision stunned many in the innovation community. Industry groups warned that this new bureaucratic hurdle would “kill NIH licensing.” They’re right, and not merely ... The NIH ‘Access Plan’ Mandate: Central Planning by Another Name The post The NIH ‘Access Plan’ Mandate: Central...| Truth on the Market
US President Donald Trump on Thursday announced steep tariffs on pharmaceuticals, heavy trucks, home fixtures and furniture, escalating his global trade war. The measures, effective October 1, mark Trump’s…| France 24
Merger-control regimes around the world have for some time now engaged with the theory of harm known as “killer acquisitions.” The idea is simple: an incumbent buys a rival in order to shut down its operations and preempt future competition. Indeed, the original paper that laid out the theory found that 5-7% of mergers may ... Killer Acquisitions: A Killer Story, But Still Not Much Evidence The post Killer Acquisitions: A Killer Story, But Still Not Much Evidence appeared first on Truth o...| Truth on the Market
Our umbrella review that revealed no links between serotonin and depression has caused shock waves among the general public, but been dismissed as old news by psychiatric opinion leaders. This disj…| Joanna Moncrieff
Trump’s lies are like zombies. Fact-checkers keep killing them, but he keeps bringing them back to life — and repeating them over and over again. The only antidote is the truth — repeated over and over again. Steven Harper is following the pandemic for Moyers on Democracy.| BillMoyers.com
